SSA110 secretome significantly increased mRNA levels of matrix metalloproteinases that enhance angiogenesis and promote tumour invasion and metastasis [31,32], and SSA57 secretome upregulated mRNA and protein expression of SCC biomarkers serpin B3 and fibronectin 1. The gene discussed is SERPINB3; the disease is neoplasm.